| Skip navigation | ||
![]() |
![]() |
![]() |
|
|
||
| Other drug names: | A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9 |
| Contents of this page: | |
|
[Posted 03/12/2008] FDA and Tibotec Therapeutics notified healthcare professionals of changes to the WARNINGS section of the prescribing information for darunavir (Prezista) tablets regarding the risk of hepatotoxicity. In clinical trials and postmarketing experience, drug induced hepatitis has been reported in patients receiving combination therapy with darunavir/ritonavir. Appropriate laboratory testing should be conducted prior to initiating therapy with darunavir/ritonavir and patients should be monitored during treatment. Increased AST/ALT monitoring should be considered in patients with underlying chronic hepatitis, cirrhosis, or in patients who have pretreatment elevations of transaminases, especially during the first several months of darunavir/ritonavir treatment. For more information visit the FDA website at: http://www.fda.gov/Safety/MedWatch, http://www.fda.gov/Safety/MedWatch and http://www.fda.gov/Drugs. |
|
Serious or potentially life-threatening reactions can occur when ritonavir is taken along with certain drugs. Therefore, do not take ritonavir with alprazolam (Xanax); amiodarone (Cordarone); astemizole (Hismanal); belladonna, phenobarbital, and ergotamine tartrate (Bellergal-S, Bel-Phen-Ergot S, Phenerbel-S); bepridil (Vascor); bromocriptine (Parlodel); bupropion (Wellbutrin); cabergoline (Dostinex); cisapride (Propulsid); clorazepate (Tranxene); clozapine (Clozaril); diazepam (Valium); dihydroergotamine (D.H.E. 45, Migranal); disopyramide (Norpace); encainide (Enkaid); ergoloid mesylates (Germinal, Hydergine); ergonovine (Ergotrate Maleate); ergotamine (Cafatine, Cafergot, Cafetrate, others); estazolam (ProSom); flecainide (Tambocor); fluoxetine (Prozac, Sarafem); flurazepam (Dalmane); meperidine (Demerol); methylergonovine (Methergine); methysergide (Sansert); mexiletine (Mexitil); midazolam (Versed); nefazadone (Serzone); pergolide (Permax); pimozide (Orap); piroxicam (Feldene); propafenone (Rythmol); propoxyphene (Darvon); quinidine; rifabutin (Mycobutin); terfenadine (Seldane); triazolam (Halcion); or zolpidem (Ambien). |
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Ritonavir is used to treat human immunodeficiency virus (HIV) infection. It belongs to a class of drugs called protease (pro' tee ace) inhibitors, which slow the spread of HIV infection in the body. It is usually taken with other antiviral medications. Ritonavir is not a cure and may not decrease the number of HIV-related illnesses. Ritonavir does not prevent the spread of HIV to other people.
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Ritonavir comes as a capsule and liquid to take by mouth. It is usually taken every 12 hours (twice a day). Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take ritonavir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Mix just one dose at a time and take the whole dose within 1 hour of mixing. Rinse the cup after each dose.
Continue to take ritonavir even if you feel well. Do not stop taking ritonavir without talking to your doctor.
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Before taking ritonavir,
Take ritonavir with food. Ritonavir liquid may be taken alone or mixed with chocolate milk or the food supplements Ensure or Advera. Do not mix it with any other fluids.
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
Side effects from ritonavir may occur. Tell your doctor if any of these symptoms are severe or do not go away:
If you experience any of the following symptoms, call your doctor immediately:
Ritonavir may increase the sugar level in your blood. If you experience any of the following symptoms, call your doctor immediately:
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/Safety/MedWatch] or by phone [1-800-332-1088].
Keep this medication in the container it came in, tightly closed, and out of reach of children. Keep retonavir capsules and liquid in the refrigerator; do not freeze. The liquid bottle in use can be stored in a cool area for up to 30 days. Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your response to ritonavir.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
|
|
Last Reviewed - 09/01/2008

AHFS® Consumer Medication Information. © Copyright, 2009. The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.
| Home | Health Topics | Drugs & Supplements | Encyclopedia | Dictionary | News | Directories | Other Resources | |
| Disclaimers | Copyright | Privacy | Accessibility | Quality Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 18 November 2009 |